Jump to any asset
849 assets, updated daily
As of September 27, 2026, Molina Healthcare Inc. (MOH) trades at $190.86. CleaRank Financial AI rates it Hold with a fair value of $209.00, 9.5% above the current price. Wall Street's consensus target is $209.00 across 19 analysts. RSI at 42 is in neutral territory, and the price is below its 50-day average of $201.53.
Molina Healthcare Inc. (MOH)
Molina Healthcare Inc. NYSE
$190.86
-2.450 (-1.27%)
At close: Sep 25, 4:00 PM EDT
AI Analyst Consensus
54 / 100
Molina Healthcare Inc. (MOH) is currently trading at $190.86, below its 50-day and 20-day moving averages, signaling near-term technical weakness. The company's consensus rating is Hold, supported by a Wall Street score of 54 and a median analyst price target of $209.00, implying a 9.5% upside. While the long-term growth outlook for the next five years is positive at 35.6% compounded annually, recent financial performance shows a decline in revenue growth and a negative profit margin, contributing to a moderate sell signal from insider transactions. The company operates within the Healthcare Plans industry, a sector that has seen a median revenue growth of 8.1%. However, MOH's own revenue growth has been negative at -5.7% in the last reported period. Its current valuation metrics, such as a Price-to-Sales ratio of 0.23 and a Price-to-Earnings ratio of 1272.40, appear stretched compared to sector averages, particularly given its negative profit margin and return on equity. The significant insider selling activity, totaling $32.7 million against $1.7 million in purchases, further tempers the bullish sentiment.
MOH Price Analysis
Market Metrics
Open
$193.59
Day Range
$189.32 to $195.81
Prev Close
$193.31
Volume
676.4K
52-Week Range
$121.06 to $244.89
Market Cap
$9.96B
Peer Benchmarking
Valuation vs Sector (Healthcare)
Performance vs XLV
Sector Position Analysis
Trading at a significant premium to sector peers (+3,889%), suggesting market expectations for superior growth or market position.
MOH Financial Performance
Revenue vs. Earnings
Annual
Quarterly
MOH Analysis
Company's Health
3/5
12-Month Analyst Target
+9.50% Upside
Median of 19 analysts (12-month)
$209.00
AI Technical Analysis
Molina Healthcare Inc. (MOH) is trading below its 50-day SMA of $201.53 and its 20-day EMA of $198.54, indicating a bearish short-term trend. The Relative Strength Index (RSI) is at 42.17, reflecting neutral momentum, while the MACD is negative at -2.56, suggesting downward pressure. The 200-day SMA at $181.10 represents a significant longer-term floor. Volume has been slightly above average recently, with the latest volume at 676,400 compared to an average of 607,110, suggesting some investor interest but not overwhelming conviction. The current price action suggests a potential for further downside towards the 200-day SMA if the bearish momentum continues.
ProTips
- Insider selling activity totaling $32.7 million warrants close attention, suggesting potential near-term headwinds for MOH stock.
- The stock's position below its 50-day and 20-day moving averages indicates a bearish technical trend, advising caution for new positions.
- Given the current unprofitability and negative profit margins, investors should closely monitor forward-looking earnings estimates and revenue growth projections for signs of sustained recovery.
Key Catalysts
Bearish
Significant Insider Selling Pressure
Insiders have sold $32.7 million worth of stock against only $1.7 million in purchases, indicating a lack of confidence in the near-term outlook.
Source: Insider TransactionsBearish
Technical Downtrend Confirmation
MOH is trading below its 50-day SMA ($201.53) and 20-day EMA ($198.54), suggesting a bearish short-term trend and potential for further price declines.
Source: Technical AnalysisBullish
Strong Forward EPS Growth Estimates
Wall Street expects EPS to grow by 85.6% next year, signaling a significant turnaround from current negative profitability.
Source: Wall Street EstimatesBullish
Projected Revenue Rebound
Revenue growth is expected to shift from -2.00% this year to +8.00% next year, indicating a recovery in the company's top line.
Source: Wall Street EstimatesMarket Outlook
Molina Healthcare Inc. (MOH) is expected to see a significant recovery in earnings and revenue over the next year, with EPS projected to grow by 85.6% and revenue by 8.00%. The median analyst price target of $209.00 suggests that the market anticipates this turnaround, offering a modest upside from the current price. The company's long-term growth prospects, estimated at 35.6% annually over the next five years, are strong. However, the path to achieving these projections is fraught with near-term challenges. The stock's current technical setup is bearish, trading below key moving averages, and significant insider selling indicates caution. The company's current unprofitability and higher-than-sector debt levels present risks that could derail the anticipated recovery if not managed effectively. Investors should monitor upcoming earnings reports for confirmation of the projected growth trajectory and profitability improvements.
Key Statistics
| Market Cap | 9.96B |
|---|---|
| P/E Ratio | 1,272.40 |
| EPS (TTM) | 0.1500 |
| Dividend Yield | 0.00% |
| 52 Week High | 244.89 |
| 52 Week Low | 121.06 |
Molina Healthcare Inc. (MOH) exhibits a high Price-to-Earnings ratio of 1272.40 and a Price-to-Sales ratio of 0.23, which appears inexpensive relative to its sector's median P/S of 3.7, but its P/E is significantly higher than the sector median of 31.9. The company is currently loss-making, with a negative profit margin of -0.02% and a negative return on equity of -0.16%, contrasting sharply with the sector's median ROE of 6.9%. Despite the current profitability challenges, forward-looking estimates suggest a significant turnaround. Wall Street expects EPS to grow from a current year estimate of $5.25 to $8.55 next year, and revenue growth is projected to rebound from -2.00% this year to +8.00% next year. The company's debt-to-equity ratio stands at 0.95, which is higher than the sector median, indicating a more leveraged capital structure. The current valuation appears to be pricing in substantial future growth, which is not yet reflected in current operational performance.
Earnings & Growth Analysis
Molina Healthcare Inc. (MOH) faces a challenging earnings environment, with current year EPS estimates at $5.25, a significant decrease from $11.03 in the prior year. Wall Street revenue estimates also show a slight contraction for the current year at -2.00%, though a strong rebound is projected for next year. The company's profit margin is currently negative at -0.02%, indicating it is not generating profits on its revenue. Forward-looking growth estimates are positive, with next year's EPS projected to increase by 85.6% and revenue by 8.00%, suggesting a strong recovery is anticipated.
Key Risks
Molina Healthcare Inc. (MOH) faces significant risks including its current unprofitability, evidenced by a negative profit margin and return on equity. The moderate sell signal from insider transactions, with $32.7 million in sales versus $1.7 million in purchases, suggests a lack of insider confidence in the near term. Also, the stock is trading below key short-term moving averages, indicating potential for further price depreciation.
Technical Indicators
| RSI (14) | 42.17 |
|---|---|
| MACD | -2.56 |
| SMA 50 | 201.53 |
| SMA 200 | 181.10 |
RSI
Neutral
SMA Cross
Bullish
Price vs SMA
Bearish
MACD
Bearish
Golden Cross in effect with the 50-day SMA ($201.53) above the 200-day SMA ($181.10), price is trading below the 50-day SMA.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.01
Weak correlation
Nasdaq 100 (QQQ)
-0.03
Weak correlation
Bitcoin (BTC)
-0.13
Weak correlation
Gold (XAU)
-0.06
Weak correlation
Check Custom Correlation
How does any other asset move with MOH? One year of daily closes, Pearson correlation.
Try
MOH Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies pick an entry style
Conservative
$188.95
Slight discount to current
Wait for small dip
Aggressive
$190.86
At current price
Enter now if confident
Risk Management
STOP LOSS
$179.24
MAX LOSS
-5.1%
Volatility-Adjusted Stop Loss
Calculated based on RSI (42.2) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$194.62
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$198.40
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$204.07
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for MOH is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 27, 2026.Growth of $10,000
A $10,000 investment in MOH in September 2016 would be worth about $32,856 today, compared with about $35,782 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in MOH today could grow to about $25,611 by 2036 in the base case, with a bull case near $137,462 and a bear case around $4,772. Projections are statistical simulations, not guarantees.
MOH Stock Price Prediction: 2030
CleaRank's simulation projects a price near $278 for MOH by 2030 in the base case, from $191 today (1.5x over 4 years). The downside path ends near $96.06. These are outcomes of a Monte Carlo simulation run on MOH's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $123 | $210 | $357 |
| 2028 | $109 | $230 | $488 |
| 2029 | $101 | $253 | $635 |
| 2030 | $96.06 | $278 | $805 |
| 2031 | $93.09 | $305 | $1,002 |
| 2032 | $91.31 | $336 | $1,233 |
| 2033 | $90.38 | $369 | $1,504 |
| 2034 | $90.11 | $405 | $1,820 |
| 2035 | $90.37 | $445 | $2,191 |
| 2036 | $91.07 | $489 | $2,624 |
Method: 10,000 simulated price paths using MOH's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
MOH Insider Trading Analysis
Bought
$1.7M
2 Transactions
Sold
$32.7M
9 Transactions
Insiders
17
Active Traders
Avg Transaction
$3.1M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2022 | ZUBRETSKY JOSEPH M
Chief Executive Officer
|
Sell | 88.9K | $31.1M |
| Oct 4, 2022 | ZUBRETSKY JOSEPH M
Chief Executive Officer
|
Sell | 90.0K | $30.4M |
| Sep 21, 2022 | ZUBRETSKY JOSEPH M
Chief Executive Officer
|
Sell | 87.9K | $29.8M |
| Apr 30, 2025 | ZUBRETSKY JOSEPH M
Chief Executive Officer
|
Sell | 87.5K | $28.0M |
| Sep 29, 2022 | ZUBRETSKY JOSEPH M
Chief Executive Officer
|
Sell | 78.2K | $25.9M |
| Sep 22, 2022 | ZUBRETSKY JOSEPH M
Chief Executive Officer
|
Sell | 30.0K | $9.9M |
| Aug 3, 2022 | WOYS JAMES E
Officer
|
Sell | 25.0K | $8.2M |
| Feb 12, 2024 | KEIM MARK LOWELL
Chief Financial Officer
|
Sell | 15.0K | $5.8M |
| Sep 8, 2022 | BARLOW JEFF D
Officer
|
Sell | 14.5K | $5.1M |
| Aug 9, 2022 | KEIM MARK LOWELL
Chief Financial Officer
|
Sell | 12.0K | $4.0M |
Page 1 of 1
Frequently Asked Questions
What is Molina Healthcare's stock forecast for 2030?
Molina Healthcare's stock forecast for 2030, based on Monte Carlo simulations, projects a base case price of $278.03. The downside scenario is $96.06, and the upside scenario reaches $804.68. These are statistical outcomes, not guarantees.
Is Molina Healthcare stock a buy right now?
Molina Healthcare (MOH) is currently rated Hold by Wall Street analysts, with a consensus score of 54. The median price target of $209.00 suggests limited upside from the current price of $190.86.
What is the current technical outlook for Molina Healthcare stock?
MOH is trading below its 50-day and 20-day moving averages, indicating a bearish short-term trend. The RSI is neutral at 42.17, but the MACD shows downward pressure, suggesting potential for further price declines towards the 200-day SMA.
Are insiders buying or selling Molina Healthcare stock?
Insiders are net sellers of Molina Healthcare stock, with total sales of $32.7 million compared to total purchases of $1.7 million. This activity contributes to a moderate sell signal.
How does Molina Healthcare's valuation compare to its sector?
Molina Healthcare's Price-to-Sales ratio of 0.23 is lower than the sector median of 3.7, but its Price-to-Earnings ratio of 1272.40 is significantly higher than the sector median of 31.9. The company's negative profit margin and ROE also lag behind sector averages.
What are the key risks facing Molina Healthcare?
Key risks include the company's current unprofitability, evidenced by negative profit margins and ROE, and the moderate sell signal from significant insider selling. Technical indicators also suggest near-term weakness.
What are Wall Street analysts' price targets for Molina Healthcare?
The median analyst price target for Molina Healthcare is $209.00, with a high of $266 and a low of $147. This implies an upside of 9.5% from the current stock price.